nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—CYP19A1—FSH signaling pathway—GRK6—Parkinson's disease	0.0471	0.0562	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—NR4A2—Parkinson's disease	0.0388	0.0462	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.0306	0.0365	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—NR4A2—Parkinson's disease	0.0294	0.035	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.0232	0.0277	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—INSR—Parkinson's disease	0.023	0.0274	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—DDC—Parkinson's disease	0.021	0.025	CbGpPWpGaD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—Parkinson's disease	0.0206	0.0245	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—PARK7—Parkinson's disease	0.0196	0.0234	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.0194	0.0232	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—MAOB—Parkinson's disease	0.0177	0.0211	CbGpPWpGaD
Cyproterone acetate—NR3C1—nerve—Parkinson's disease	0.0163	0.101	CbGeAlD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.0147	0.0176	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.0147	0.0175	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—BDNF—Parkinson's disease	0.0146	0.0174	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—PENK—Parkinson's disease	0.0137	0.0163	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—SOD1—Parkinson's disease	0.0122	0.0146	CbGpPWpGaD
Cyproterone acetate—NR3C1—Signaling events mediated by HDAC Class II—ADRBK1—Parkinson's disease	0.0122	0.0145	CbGpPWpGaD
Cyproterone acetate—NR3C1—hindbrain—Parkinson's disease	0.0122	0.0758	CbGeAlD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.012	0.0143	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.0116	0.0138	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.0112	0.0133	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.0106	0.0127	CbGpPWpGaD
Cyproterone acetate—CYP19A1—forebrain—Parkinson's disease	0.0105	0.0654	CbGeAlD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.0105	0.0125	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00972	0.0116	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00959	0.0114	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—HSPA8—Parkinson's disease	0.00958	0.0114	CbGpPWpGaD
Cyproterone acetate—AR—forebrain—Parkinson's disease	0.0093	0.0579	CbGeAlD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.00919	0.0109	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00861	0.0103	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00788	0.00939	CbGpPWpGaD
Cyproterone acetate—AR—cardiovascular system—Parkinson's disease	0.00786	0.0489	CbGeAlD
Cyproterone acetate—AR—FOXA1 transcription factor network—INS—Parkinson's disease	0.00771	0.00919	CbGpPWpGaD
Cyproterone acetate—NR3C1—embryo—Parkinson's disease	0.00761	0.0474	CbGeAlD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TH—Parkinson's disease	0.00738	0.00879	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HSPA8—Parkinson's disease	0.00727	0.00866	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.00719	0.00857	CbGpPWpGaD
Cyproterone acetate—NR3C1—brainstem—Parkinson's disease	0.00698	0.0434	CbGeAlD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.00697	0.00831	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—Parkinson's disease	0.00697	0.0083	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTA4—Parkinson's disease	0.00691	0.00823	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00681	0.00812	CbGpPWpGaD
Cyproterone acetate—NR3C1—forebrain—Parkinson's disease	0.00673	0.0419	CbGeAlD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00648	0.00772	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00618	0.00737	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—MAOB—Parkinson's disease	0.00616	0.00733	CbGpPWpGaD
Cyproterone acetate—CYP19A1—head—Parkinson's disease	0.00601	0.0374	CbGeAlD
Cyproterone acetate—AR—spinal cord—Parkinson's disease	0.00599	0.0373	CbGeAlD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.00597	0.00711	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00595	0.00709	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00586	0.00698	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—Parkinson's disease	0.00585	0.00697	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—EDN1—Parkinson's disease	0.00581	0.00692	CbGpPWpGaD
Cyproterone acetate—CYP19A1—nervous system—Parkinson's disease	0.0057	0.0355	CbGeAlD
Cyproterone acetate—NR3C1—cardiovascular system—Parkinson's disease	0.00569	0.0354	CbGeAlD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—Parkinson's disease	0.00551	0.00657	CbGpPWpGaD
Cyproterone acetate—CYP19A1—central nervous system—Parkinson's disease	0.00549	0.0342	CbGeAlD
Cyproterone acetate—AR—head—Parkinson's disease	0.00532	0.0331	CbGeAlD
Cyproterone acetate—AR—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.00529	0.0063	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00512	0.00611	CbGpPWpGaD
Cyproterone acetate—AR—nervous system—Parkinson's disease	0.00505	0.0314	CbGeAlD
Cyproterone acetate—NR3C1—medulla oblongata—Parkinson's disease	0.00487	0.0303	CbGeAlD
Cyproterone acetate—AR—central nervous system—Parkinson's disease	0.00486	0.0302	CbGeAlD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00469	0.00559	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP2D6—Parkinson's disease	0.00458	0.00545	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—MAPK8—Parkinson's disease	0.00455	0.00542	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00452	0.00538	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00451	0.00538	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—Parkinson's disease	0.00445	0.0053	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00445	0.0053	CbGpPWpGaD
Cyproterone acetate—NR3C1—midbrain—Parkinson's disease	0.00445	0.0277	CbGeAlD
Cyproterone acetate—CYP19A1—brain—Parkinson's disease	0.00436	0.0271	CbGeAlD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—ABL1—Parkinson's disease	0.00435	0.00518	CbGpPWpGaD
Cyproterone acetate—NR3C1—spinal cord—Parkinson's disease	0.00434	0.027	CbGeAlD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00433	0.00515	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP2E1—Parkinson's disease	0.00418	0.00499	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00417	0.00497	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00413	0.00492	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.00401	0.00478	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00389	0.00463	CbGpPWpGaD
Cyproterone acetate—AR—brain—Parkinson's disease	0.00386	0.024	CbGeAlD
Cyproterone acetate—NR3C1—head—Parkinson's disease	0.00386	0.024	CbGeAlD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00383	0.00456	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—ABL1—Parkinson's disease	0.00374	0.00446	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.0037	0.00441	CbGpPWpGaD
Cyproterone acetate—NR3C1—nervous system—Parkinson's disease	0.00366	0.0228	CbGeAlD
Cyproterone acetate—AR—Gene Expression—PRKRA—Parkinson's disease	0.00361	0.00431	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.0036	0.00429	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.00355	0.00423	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00353	0.0042	CbGpPWpGaD
Cyproterone acetate—NR3C1—central nervous system—Parkinson's disease	0.00352	0.0219	CbGeAlD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.00349	0.00416	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—COMT—Parkinson's disease	0.00347	0.00413	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTP1—Parkinson's disease	0.00345	0.00411	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—MAPK8—Parkinson's disease	0.00345	0.00411	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—MAOA—Parkinson's disease	0.00344	0.0041	CbGpPWpGaD
Cyproterone acetate—NR3C1—cerebellum—Parkinson's disease	0.00344	0.0214	CbGeAlD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—COMT—Parkinson's disease	0.00342	0.00407	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTP1—Parkinson's disease	0.0034	0.00406	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00328	0.00391	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTM1—Parkinson's disease	0.00317	0.00378	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00317	0.00377	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.00315	0.00375	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00313	0.00373	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00281	0.00335	CbGpPWpGaD
Cyproterone acetate—NR3C1—brain—Parkinson's disease	0.00279	0.0174	CbGeAlD
Cyproterone acetate—NR3C1—Gene Expression—PRKRA—Parkinson's disease	0.00274	0.00327	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00268	0.00319	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—TAF1—Parkinson's disease	0.00255	0.00303	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR4A2—Parkinson's disease	0.00255	0.00303	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—INS—Parkinson's disease	0.00246	0.00293	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Parkinson's disease	0.00243	0.0029	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00239	0.00285	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—CTGF—Parkinson's disease	0.00238	0.00284	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ND3—Parkinson's disease	0.00225	0.00268	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MCCC1—Parkinson's disease	0.00225	0.00268	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.00214	0.00255	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—OMD—Parkinson's disease	0.00211	0.00252	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TALDO1—Parkinson's disease	0.00211	0.00252	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00209	0.00249	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.00209	0.00248	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RPL6—Parkinson's disease	0.00204	0.00243	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NDUFB11—Parkinson's disease	0.002	0.00239	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NR4A2—Parkinson's disease	0.00193	0.0023	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—TAF1—Parkinson's disease	0.00193	0.0023	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GCH1—Parkinson's disease	0.00191	0.00228	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.00184	0.00219	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—CTGF—Parkinson's disease	0.00181	0.00216	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.00177	0.00211	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—Parkinson's disease	0.00176	0.0021	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00172	0.00205	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—DBH—Parkinson's disease	0.0017	0.00203	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—FBP1—Parkinson's disease	0.0017	0.00203	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GBA—Parkinson's disease	0.0017	0.00203	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.00163	0.00194	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00159	0.00189	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.00158	0.00189	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—Parkinson's disease	0.00155	0.00185	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RPL6—Parkinson's disease	0.00154	0.00184	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RPL23A—Parkinson's disease	0.00154	0.00184	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RPL14—Parkinson's disease	0.00154	0.00184	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.00152	0.00181	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RPS8—Parkinson's disease	0.00144	0.00171	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—Parkinson's disease	0.00133	0.00159	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.00129	0.00154	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—DDC—Parkinson's disease	0.00125	0.00149	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.00122	0.00146	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTA4—Parkinson's disease	0.00118	0.00141	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RPL23A—Parkinson's disease	0.00117	0.00139	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RPL14—Parkinson's disease	0.00117	0.00139	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00117	0.00139	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HSPA8—Parkinson's disease	0.00115	0.00137	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.00115	0.00137	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—CTGF—Parkinson's disease	0.00115	0.00137	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RPS8—Parkinson's disease	0.00109	0.0013	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—Parkinson's disease	0.00107	0.00128	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PLA2G6—Parkinson's disease	0.00106	0.00127	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MAOB—Parkinson's disease	0.00105	0.00125	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HSPA1A—Parkinson's disease	0.00105	0.00125	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.001	0.00119	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000929	0.00111	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HSPA8—Parkinson's disease	0.000875	0.00104	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—CTGF—Parkinson's disease	0.000871	0.00104	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HSPA1A—Parkinson's disease	0.000796	0.000949	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2D6—Parkinson's disease	0.000782	0.000932	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CTGF—Parkinson's disease	0.000768	0.000915	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2E1—Parkinson's disease	0.000716	0.000853	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NQO1—Parkinson's disease	0.000708	0.000843	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TH—Parkinson's disease	0.000697	0.000831	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYCS—Parkinson's disease	0.00067	0.000798	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—COMT—Parkinson's disease	0.000593	0.000707	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTP1—Parkinson's disease	0.00059	0.000703	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MAOA—Parkinson's disease	0.000589	0.000702	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HMOX1—Parkinson's disease	0.000582	0.000693	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCB1—Parkinson's disease	0.000559	0.000666	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTM1—Parkinson's disease	0.000542	0.000646	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GPX1—Parkinson's disease	0.000519	0.000619	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTHFR—Parkinson's disease	0.000479	0.000571	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOE—Parkinson's disease	0.000446	0.000532	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—INS—Parkinson's disease	0.000381	0.000454	CbGpPWpGaD
